Skip to main content
. 2011 Jun 27;11:50. doi: 10.1186/1472-6882-11-50

Table 1.

Baseline characteristics of the two study groups

Characteristic MSM (N = 25) Placebo (N = 25) p value*
Kellgren and Lawrence Grade
 Grade 1 4 8
 Grade 2 7 6
 Grade 3 4 6
 Grade 4 10 5 0.324
Male gender 4 13 0.007*
Age 67.0 ± 9.8 71.0 ± 8.3 0.203
Body mass index (BMI) 31.4 ± 5.4 28.6 ± 3.09 0.037*
WOMAC (0-100 mm scale)
 Pain subscale 42.4 ± 25.7 45.9 ± 27.4 0.641
 Stiffness subscale 46.7 ± 24.8 43.0 ± 35.6 0.671
 Function subscale 39.9 ± 21.2 47.4 ± 21.9 0.221
 Aggregated total score 40.9 ± 20.3 47.0 ± 22.2 0.100
ALF (seconds)
 8 meter walk time 9.4 ± 3.9 8.2 ± 2.1 0.172
 Stand-sit-stand transfer time 10.4 ± 5.3 8.4 ± 2.4 0.106
 Stair ascent and descent time 23.9 ± 15.1 16.5 ± 5.8 0.029*
 ALF score 43.6 ± 23.2 33.1 ± 9.6 0.043*
SF-36 (0-100 scale)
 SF-36 score results 54.1 ± 18.9 58.0 ± 17.2 0.446
Visual-analogue-scale for pain 3.78 ± 3.04 4.60 ± 2.74 0.320
Knee Society Knee Score 60.04 ± 15.6 59.5 ± 17.1 0.911
Knee Society Function Score 60.4 ± 17.2 58.9 ± 13.1 0.734

Values are presented as mean ± SD.

* The significance threshold was set at p ≤ 0.05.

MSM = methylsulfonylmethane; WOMAC = Western Ontario and McMaster Osteoarthritis Index; ALF = aggregated locomotor function; SF-36 = 36-item short-form health survey.

There were significant differences between the groups at baseline in gender, BMI and ALF score. Results of the study were adjusted to account for these differences.